Protalix BioTherapeutics
PLX
#8714
Rank
A$0.16 B
Marketcap
$2.18
Share price
13.71%
Change (1 day)
3.01%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total debt

Total debt on the balance sheet as of June 2024 : A$40.42 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total debt is A$40.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Protalix BioTherapeutics - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$38.57 M-21.58%
2022-12-31A$49.19 M6.55%
2021-12-31A$46.16 M-44.88%
2020-12-31A$83.75 M-3.75%
2019-12-31A$87.01 M27.8%
2018-12-31A$68.08 M1.86%
2017-12-31A$66.84 M-34.19%
2016-12-31A$0.10 B2.63%
2015-12-31A$98.96 M20.26%
2014-12-31A$82.29 M9.48%
2013-12-31A$75.16 M
1999-12-31A$0.08 M-15.98%
1998-12-31A$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$0.68 B 1,600.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.38 B 861.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$102.96 B 254,630.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.79 B 73,603.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel